Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Baxter
Healthtrust
QuintilesIMS
Deloitte
Argus Health
Cipla
US Department of Justice
Citi
Federal Trade Commission

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090077

« Back to Dashboard

NDA 090077 describes CAFFEINE CITRATE, which is a drug marketed by Aurobindo Pharma Ltd, Exela Pharma Science, Fresenius Kabi Usa, Luitpold, Sagent Pharms, Sun Pharma Global, and Exela Pharma Scs Llc, and is included in eleven NDAs. It is available from seven suppliers. Additional details are available on the CAFFEINE CITRATE profile page.

The generic ingredient in CAFFEINE CITRATE is caffeine citrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the caffeine citrate profile page.
Summary for 090077
Tradename:CAFFEINE CITRATE
Applicant:Sun Pharma Global
Ingredient:caffeine citrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 090077
Ingredient-typeXanthines
Physiological EffectCentral Nervous System Stimulation
Suppliers and Packaging for NDA: 090077
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 090077 ANDA Sun Pharma Global FZE 47335-289 47335-289-40 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-289-40) > 3 mL in 1 VIAL, SINGLE-DOSE
CAFFEINE CITRATE caffeine citrate SOLUTION;INTRAVENOUS 090077 ANDA Sun Pharma Global FZE 47335-289 47335-289-27 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-289-27) > 3 mL in 1 VIAL, SINGLE-DOSE (47335-289-26)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrengthEQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Approval Date:Sep 30, 2009TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Army
US Department of Justice
Merck
Express Scripts
Deloitte
Colorcon
UBS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot